Secukinumab improves patient-reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo-controlled clinical trials.

Strober, Bruce

Secukinumab improves patient-reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo-controlled clinical trials. [electronic resource] - International journal of dermatology Apr 2016 - 401-7 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1365-4632

10.1111/ijd.13236 doi


Adult
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Double-Blind Method
Female
Humans
Immunologic Factors--therapeutic use
Male
Middle Aged
Pain--etiology
Patient Reported Outcome Measures
Pruritus--etiology
Psoriasis--complications
Severity of Illness Index
Symptom Assessment